HTG Molecular Diagnostics, Inc. (HTGMQ)
0.0001
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
HTG Molecular Diagnostics Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2023 | 16.43 |
| December 31, 2022 | 1.632 |
| September 30, 2022 | 8.499 |
| June 30, 2022 | 2.537 |
| March 31, 2022 | 1.312 |
| December 31, 2021 | 1.558 |
| September 30, 2021 | 1.113 |
| June 30, 2021 | 0.8492 |
| March 31, 2021 | 0.9988 |
| December 31, 2020 | 1.222 |
| September 30, 2020 | 1.094 |
| June 30, 2020 | 0.974 |
| March 31, 2020 | 0.7561 |
| December 31, 2019 | 0.71 |
| September 30, 2019 | 0.6201 |
| June 30, 2019 | 1.527 |
| March 31, 2019 | 1.076 |
| December 31, 2018 | 0.7904 |
| Date | Value |
|---|---|
| September 30, 2018 | 0.4229 |
| June 30, 2018 | 0.3525 |
| March 31, 2018 | 0.3084 |
| December 31, 2017 | -2.861 |
| September 30, 2017 | -1.630 |
| June 30, 2017 | -5.739 |
| March 31, 2017 | -0.9446 |
| December 31, 2016 | -2.106 |
| September 30, 2016 | -5.940 |
| June 30, 2016 | 3.607 |
| March 31, 2016 | 1.494 |
| December 31, 2015 | 0.6391 |
| September 30, 2015 | 0.4956 |
| June 30, 2015 | 0.7103 |
| March 31, 2015 | -1.282 |
| December 31, 2014 | -1.450 |
| September 30, 2014 | -1.121 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Dynatronics Corp. | -- |
| Longport, Inc. | -- |
| Bionik Laboratories Corp. | -- |
| ViewRay, Inc. | -- |
| Biotricity, Inc. | -0.7993 |